Внесок користувача
- 18:46, 30 листопада 2016 (різн. • історія) . . (-2) . . м For many years, antibodies to the V1/V2 domain were considered to be too strain specific and of little use in vaccines designed to elicit broad protective immunity (поточна)
- 16:55, 30 листопада 2016 (різн. • історія) . . (+3594) . . Н For many years, antibodies to the V1/V2 domain were considered to be too strain specific and of little use in vaccines designed to elicit broad protective immunity (Створена сторінка: For many several years, antibodies to the V1/V2 area ended up considered to be too pressure specific and of small use in vaccines created to elicit broad protec...)
- 13:31, 30 листопада 2016 (різн. • історія) . . (+3401) . . Н Mutations at glycosylation sites in the V1 domain of CRF01 AE viruses that determine sensitivity and resistance to neutralization are located at the junction of the A and B strands at positions 136 and 149 (Створена сторінка: Mutations at glycosylation internet sites in the V1 area of CRF01_AE viruses that figure out sensitivity and resistance to neutralization are found at the junct...) (поточна)
- 16:31, 29 листопада 2016 (різн. • історія) . . (+532) . . Н Differentiation was further validated at the protein level by immunofluorescent staining and quantification of cell numbers for KRT5 (Створена сторінка: Differentiation was additional [http://bestofhousemusic.be/members/list5drop/activity/187457/ In the DEKA mutant, the movement of Lys180 aspect chain is compara...) (поточна)
- 15:56, 29 листопада 2016 (різн. • історія) . . (+4100) . . Н The Notch signaling pathway contains multiple ligands, receptors and downstream effectors (The Notch signaling pathway contains multiple ligands, receptors and downstream effectors) (поточна)